National and Kapodistrian University of Athens
Οι παράμετροι που επηρεάζουν την τροποποιημένη αποδέσμευση από υβριδικά σωματίδια
Abstract
dc:descriptionNanotechnology has emerged as an asset in pharmaceutical science by enhancing effective pharmacotherapy via targeted drug delivery of pharmacologically active compounds with challenging physicochemical properties. Despite its promise, pharmaceutical nanotechnology applications still face hurdles, particularly due to toxicity-related concerns. Within this framework, hybrid nanoparticles composed of lipids and copolymers have garnered increasing interest as drug delivery carriers, combining the biocompatibility of lipids with the structural stability of copolymers. Notably, copolymers’ tailor-made properties offer a significant advantage in customizable therapeutic strategies according to intended needs. To date, the clinical application of such hybrid systems remains limited though due to various challenges including their complexity. Although lipid/copolymer hybrid particles have been extensively studied, especially those based on block copolymer architectures, a distinct gap persists in the literature concerning hybrid systems comprised of lipids and copolymers with alternative architectures, such as statistical or hyperbranched copolymers. This doctoral dissertation aims to explore the rational design of hybrid nanoparticles composed of marketed available and extensively used phospholipids and novel amphiphilic linear copolymers with random sequence of monomer (statistical or random copolymers). The main objective is to investigate the design parameters that influence lipid/copolymer hybrid particles performance and their modified release capability. A variety of hybrid systems were systematically studied using a broad spectrum of complementary techniques to elucidate the molecular interactions between the biomaterials and their self-assembly into nanoparticles with unique features and properties. Specifically, zwitterionic DSPC (1,2-dioctadecanoyl-sn-glycero-3-phosphocholine) and DOPC (1,2-dioleoyl-sn-glycero-3-phosphocholine) phospholipids were combined with copolymers comprising a hydrophilic segment; namely POEGMA [poly(Oligo (ethylene glycol) methyl ether methacrylate)], and hydrophobic segments such as PLMA [poly(lauryl methacrylate)] or pH and temperature-responsive PDIPAEMA [poly(2-(diisopropylamino) ethyl methacrylate)]. The investigation focused on the effects of the hydrophilic side chain length and comonomer ratio on hybrid nanoparticles characteristics. The lipid to copolymer weight ratio and the lipid composition were also investigated as main design parameters. Preformulation studies were conducted via differential scanning calorimetry (DSC) on lipidic and hybrid bilayers. Afterwards, hybrid structures were prepared using the thin film hydration method, followed by size reduction via probe sonication. The hybrid nature of the particles was confirmed, and their physicochemical attributes were characterized through regulatory-standard techniques such as Dynamic Light Scattering (DLS), and advanced methodologies including Static Light Scattering (SLS), microDifferential Scanning Calorimetry (microDSC), High-Resolution Ultrasound Spectroscopy (HR-US), and cryogenic Transmission Electron Microscopy (cryo-TEM). Fluorescence spectroscopy utilizing hydrophobic probes (e.g., pyrene, Laurdan) provided insight into membrane polarity and fluidity. Biocompatibility was evaluated primarily via the well-established in vitro MTS assay, confirming the safety profile of the majority of investigated hybrid systems. Selected formulations were tested for their capability for drug encapsulation using methotrexate as a model hydrophobic therapeutic agent. The innovation of this work lies in both the selection of biomaterials and the application of advanced characterization techniques, marking the first-time preparation and comprehensive evaluation of DSPC:DOPC:P(OEGMA-co-LMA) and DSPC:DOPC:P(OEGMA-co-DIPAEMA) hybrid particles. Remarkably, the DSPC:P(OEGMA-co-DIPAEMA) systems demonstrated statistically significant in vitro anticancer activity and selectivity in cancer cell lines, suggesting that these systems may inhibit the intrinsic toxicity of methotrexate. Furthermore, they exhibited modified release capability due to the in vitro pH sensitive drug release profile as well as sustained release under acidic conditions for up to 24 hours. The random architecture of the copolymers was found to be a critical parameter influencing both the behavior of empty and drug-loaded nanoparticles. Ultimately, the overall performance of these lipid/statistical copolymer hybrid nanoparticles is governed by themolecular interactions of the constituent biomaterials and their co-assembly, modulated by key design parameters such as copolymer architecture, lipid to polymer ratio, lipid composition, and the hydrophilic to hydrophobic balance. In conclusion, the unmet need for innovative drug delivery systems capable of sustained release, along with the imperative need for an in-depth understanding of their properties, has driven the present dissertation toward the development of hybrid lipid/random copolymer carriers. This work highlights the key design parameters and underscores the importance of investigating these systems via multiple complimentary characterization methods, with the ultimate goal of their rapid and effective clinical translation. Consequently, the hybrid lipid/ random copolymer systems, explored extensively in this doctoral thesis, may serve as promising prototypical systems for the study of interactions among materials of diverse chemical nature and origin, with promising implications for applications in both Pharmaceutical Technology and Biomimetics.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Triantafyllopoulou, Efstathia
- Τριανταφυλλοπούλου, Ευσταθία
Subjects
dc:subject × 22- Υβριδικά σωματίδια
- Νανοσωματίδια
- Φαρμακευτική Τεχνολογία
- Φαρμακευτική νανοτεχνολογία
- Φωσφολιπίδια
- Στατιστικά συμπολυμερή
- Συστήματα μεταφοράς φαρμάκων
- Hybrid particles
- Nanoparticles
- Pharmaceutical Technology
- Pharmaceutical nanotechnology
- Statistical copolymers
- Phospholipids
- Drug delivery systems
- Επιστήμες Υγείας
- Ιατρική και Επιστήμες Υγείας
- Επιστήμες υγείας, άλλοι τομείς
- Επαγγέλματα υγείας
- Health Sciences
- Medical and Health Sciences
- Health sciences, miscellaneous
- Health Professions
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/60235